Depreciation of INTEGRATED BIOPHARMA INC from 30 Sep 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
INTEGRATED BIOPHARMA INC quarterly and annual Depreciation in USD history and change rate from 30 Sep 2011 to 30 Sep 2025.
  • INTEGRATED BIOPHARMA INC Depreciation for the quarter ending 30 Sep 2025 was $77,000, a 9.4% decline year-over-year.
  • INTEGRATED BIOPHARMA INC Depreciation for the twelve months ending 30 Sep 2025 was $310,000, a 1.6% decline year-over-year.
  • INTEGRATED BIOPHARMA INC annual Depreciation for 2025 was $318,000, a 3.6% increase from 2024.
  • INTEGRATED BIOPHARMA INC annual Depreciation for 2024 was $307,000, a 13% decline from 2023.
  • INTEGRATED BIOPHARMA INC annual Depreciation for 2023 was $351,000, a 4.5% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

INTEGRATED BIOPHARMA INC Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $310,000 $77,000 -$8,000 -9.4% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2026 Q1
Q2 2025 $318,000 $74,000 -$1,000 -1.3% 01 Apr 2025 30 Jun 2025 10-K 23 Sep 2025 2025 FY
Q1 2025 $319,000 $76,000 -$1,000 -1.3% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q3
Q4 2024 $320,000 $83,000 +$5,000 +6.4% 01 Oct 2024 31 Dec 2024 10-Q 13 Feb 2025 2025 Q2
Q3 2024 $315,000 $85,000 +$8,000 +10% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2026 Q1
Q2 2024 $307,000 $75,000 -$9,000 -11% 01 Apr 2024 30 Jun 2024 10-K 23 Sep 2025 2025 FY
Q1 2024 $316,000 $77,000 -$9,000 -10% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q3
Q4 2023 $325,000 $78,000 -$15,000 -16% 01 Oct 2023 31 Dec 2023 10-Q 13 Feb 2025 2025 Q2
Q3 2023 $340,000 $77,000 -$11,000 -12% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2025 Q1
Q2 2023 $351,000 $84,000 -$5,000 -5.6% 01 Apr 2023 30 Jun 2023 10-K 20 Sep 2024 2024 FY
Q1 2023 $356,000 $86,000 +$3,000 +3.6% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q3
Q4 2022 $353,000 $93,000 +$14,000 +18% 01 Oct 2022 31 Dec 2022 10-Q 12 Feb 2024 2024 Q2
Q3 2022 $339,000 $88,000 +$3,000 +3.5% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2024 Q1
Q2 2022 $336,000 $89,000 +$5,000 +6% 01 Apr 2022 30 Jun 2022 10-K 15 Sep 2023 2023 FY
Q1 2022 $331,000 $83,000 $0 0% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q3
Q4 2021 $331,000 $79,000 -$8,000 -9.2% 01 Oct 2021 31 Dec 2021 10-Q 10 Feb 2023 2023 Q2
Q3 2021 $339,000 $85,000 +$2,000 +2.4% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2023 Q1
Q2 2021 $337,000 $84,000 +$11,000 +15% 01 Apr 2021 30 Jun 2021 10-K 13 Sep 2022 2022 FY
Q1 2021 $326,000 $83,000 +$4,000 +5.1% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q3
Q4 2020 $322,000 $87,000 +$18,000 +26% 01 Oct 2020 31 Dec 2020 10-Q 10 Feb 2022 2022 Q2
Q3 2020 $304,000 $83,000 -$8,000 -8.8% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q1
Q2 2020 $312,000 $73,000 -$14,000 -16% 01 Apr 2020 30 Jun 2020 10-K 02 Sep 2021 2021 FY
Q1 2020 $326,000 $79,000 +$10,000 +14% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2020 2020 Q3
Q4 2019 $316,000 $69,000 +$3,000 +4.5% 01 Oct 2019 31 Dec 2019 10-Q 12 Feb 2020 2020 Q2
Q3 2019 $313,000 $91,000 +$25,000 +38% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2021 Q1
Q2 2019 $288,000 $87,000 +$37,000 +74% 01 Apr 2019 30 Jun 2019 10-K 23 Sep 2020 2020 FY
Q1 2019 $251,000 $69,000 +$12,000 +21% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q3
Q4 2018 $239,000 $66,000 +$9,000 +16% 01 Oct 2018 31 Dec 2018 10-Q 12 Feb 2020 2020 Q2
Q3 2018 $230,000 $66,000 -$9,000 -12% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2020 Q1
Q2 2018 $239,000 $50,000 -$19,000 -28% 01 Apr 2018 30 Jun 2018 10-K 29 Aug 2019 2019 FY
Q1 2018 $258,000 $57,000 -$14,000 -20% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q3
Q4 2017 $272,000 $57,000 -$23,000 -29% 01 Oct 2017 31 Dec 2017 10-Q 15 May 2019 2019 Q3
Q3 2017 $295,000 $75,000 +$3,000 +4.2% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018 2019 Q1
Q2 2017 $292,000 $69,000 +$3,000 +4.5% 01 Apr 2017 30 Jun 2017 10-K 12 Sep 2018 2018 FY
Q1 2017 $289,000 $71,000 +$6,000 +9.2% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q3
Q4 2016 $283,000 $80,000 +$24,000 +43% 01 Oct 2016 31 Dec 2016 10-Q 09 Feb 2018 2018 Q2
Q3 2016 $259,000 $72,000 +$13,000 +22% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2018 Q1
Q2 2016 $246,000 $66,000 $0 0% 01 Apr 2016 30 Jun 2016 10-K 01 Sep 2017 2017 FY
Q1 2016 $246,000 $65,000 -$6,000 -8.5% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q3
Q4 2015 $252,000 $56,000 -$14,000 -20% 01 Oct 2015 31 Dec 2015 10-Q 10 Feb 2017 2017 Q2
Q3 2015 $266,000 $59,000 -$2,000 -3.3% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2017 Q1
Q2 2015 $268,000 $66,000 +$8,000 +14% 01 Apr 2015 30 Jun 2015 10-K 02 Sep 2016 2016 FY
Q1 2015 $260,000 $71,000 +$11,000 +18% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016 2016 Q3
Q4 2014 $249,000 $70,000 +$4,000 +6.1% 01 Oct 2014 31 Dec 2014 10-Q 19 Feb 2016 2016 Q2
Q3 2014 $245,000 $61,000 -$8,000 -12% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015 2016 Q1
Q2 2014 $253,000 $58,000 -$16,000 -22% 01 Apr 2014 30 Jun 2014 10-K 04 Sep 2015 2015 FY
Q1 2014 $269,000 $60,000 -$11,000 -15% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015 2015 Q3
Q4 2013 $280,000 $66,000 -$5,000 -7% 01 Oct 2013 31 Dec 2013 10-Q 17 Feb 2015 2015 Q2
Q3 2013 $285,000 $69,000 -$4,000 -5.5% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014 2015 Q1
Q2 2013 $289,000 $74,000 -$40,000 -35% 01 Apr 2013 30 Jun 2013 10-K 08 Sep 2014 2014 FY
Q1 2013 $329,000 $71,000 -$15,000 -17% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014 2014 Q3
Q4 2012 $344,000 $71,000 -$2,000 -2.7% 01 Oct 2012 31 Dec 2012 10-Q/A 13 Feb 2014 2014 Q2
Q3 2012 $346,000 $73,000 -$13,000 -15% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013 2014 Q1
Q2 2012 $359,000 $114,000 01 Apr 2012 30 Jun 2012 10-K 30 Sep 2013 2013 FY
Q1 2012 $86,000 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q3
Q4 2011 $73,000 01 Oct 2011 31 Dec 2011 10-Q 19 Feb 2013 2013 Q2
Q3 2011 $86,000 01 Jul 2011 30 Sep 2011 10-Q 19 Nov 2012 2013 Q1

INTEGRATED BIOPHARMA INC Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $318,000 +$11,000 +3.6% 01 Jul 2024 30 Jun 2025 10-K 23 Sep 2025 2025 FY
2024 $307,000 -$44,000 -13% 01 Jul 2023 30 Jun 2024 10-K 23 Sep 2025 2025 FY
2023 $351,000 +$15,000 +4.5% 01 Jul 2022 30 Jun 2023 10-K 20 Sep 2024 2024 FY
2022 $336,000 -$1,000 -0.3% 01 Jul 2021 30 Jun 2022 10-K 15 Sep 2023 2023 FY
2021 $337,000 +$25,000 +8% 01 Jul 2020 30 Jun 2021 10-K 13 Sep 2022 2022 FY
2020 $312,000 +$24,000 +8.3% 01 Jul 2019 30 Jun 2020 10-K 02 Sep 2021 2021 FY
2019 $288,000 +$49,000 +21% 01 Jul 2018 30 Jun 2019 10-K 23 Sep 2020 2020 FY
2018 $239,000 -$53,000 -18% 01 Jul 2017 30 Jun 2018 10-K 29 Aug 2019 2019 FY
2017 $292,000 +$46,000 +19% 01 Jul 2016 30 Jun 2017 10-K 12 Sep 2018 2018 FY
2016 $246,000 -$22,000 -8.2% 01 Jul 2015 30 Jun 2016 10-K 01 Sep 2017 2017 FY
2015 $268,000 +$15,000 +5.9% 01 Jul 2014 30 Jun 2015 10-K 02 Sep 2016 2016 FY
2014 $253,000 -$36,000 -12% 01 Jul 2013 30 Jun 2014 10-K 04 Sep 2015 2015 FY
2013 $289,000 -$70,000 -19% 01 Jul 2012 30 Jun 2013 10-K 08 Sep 2014 2014 FY
2012 $359,000 01 Jul 2011 30 Jun 2012 10-K 30 Sep 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.